Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr160 Inhibitors

Olr160 inhibitors are a specialized class of chemical compounds designed to target and inhibit the Olr160 receptor, a member of the olfactory receptor family within the G-protein coupled receptor (GPCR) superfamily. These receptors, including Olr160, are integral to the olfactory system, playing a critical role in detecting odorant molecules and translating these chemical signals into neural signals that the brain interprets as smells. The Olr160 receptor functions by binding to specific odorant ligands, which triggers a cascade of intracellular signaling events. These events eventually lead to the activation of neural pathways responsible for processing and perceiving various odors. Inhibitors of Olr160 are developed to disrupt this signaling process by binding to the receptor, thereby preventing its natural ligands from activating it. This inhibition can occur through direct competition at the receptor's active site, where the odorant molecules typically bind, or by interacting with allosteric sites, inducing conformational changes that reduce the receptor's ability to function effectively.

The development of Olr160 inhibitors involves a meticulous and comprehensive approach to optimizing their chemical properties, such as binding affinity, selectivity, and stability. Researchers often employ molecular modeling and docking simulations to predict how these inhibitors interact with the Olr160 receptor, providing valuable insights into the receptor's structure and identifying potential binding sites that are crucial for effective inhibition. High-throughput screening of chemical libraries is another essential step in identifying lead compounds with promising inhibitory effects on Olr160. Once these lead compounds are identified, they undergo structure-activity relationship (SAR) studies to refine their chemical structures, enhancing their potency, selectivity, and overall stability while minimizing off-target effects on other receptors. This refinement process often involves modifying the core chemical scaffold or altering functional groups to improve interactions with the receptor. Additionally, properties such as solubility, lipophilicity, and metabolic stability are carefully considered to ensure that these inhibitors can function effectively under physiological conditions. Through this meticulous development process, Olr160 inhibitors provide valuable insights into the molecular mechanisms underlying olfactory receptor function and contribute to the broader understanding of GPCR-mediated signal transduction, particularly in the context of sensory perception and olfactory signaling.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

EGFR inhibitor, potentially disrupts growth factor signaling pathways involving Olr160.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

RAF inhibitor, might influence multiple signaling pathways affecting Olr160.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$118.00
$337.00
$520.00
$832.00
$1632.00
10
(0)

BCL-2 inhibitor, could modulate apoptosis pathways potentially linked to Olr160.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Src family kinase inhibitor, may affect signaling pathways where Olr160 is involved.

Sunitinib Malate

341031-54-7sc-220177
sc-220177A
sc-220177B
10 mg
100 mg
3 g
$197.00
$520.00
$1093.00
4
(1)

Multi-kinase inhibitor, potentially modulates various signaling pathways involving Olr160.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

CDK4/6 inhibitor, might impact cell cycle regulation pathways linked to Olr160.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Dual EGFR and HER2 inhibitor, potentially disrupts pathways Olr160 is involved in.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitor, may influence protein degradation processes involving Olr160.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$209.00
$413.00
9
(1)

BCR-ABL inhibitor, might influence signaling pathways related to Olr160's function.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

BCR-ABL tyrosine kinase inhibitor, potentially affects signaling pathways relevant to Olr160.